Elisabeth M. Battinelli, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Platelets | 26 | 2024 | 2520 | 4.930 |
Why?
|
Megakaryocytes | 9 | 2022 | 565 | 2.740 |
Why?
|
Neovascularization, Pathologic | 6 | 2024 | 2640 | 1.040 |
Why?
|
Angiopoietin-1 | 1 | 2024 | 122 | 0.910 |
Why?
|
Platelet Count | 1 | 2024 | 777 | 0.760 |
Why?
|
Neovascularization, Physiologic | 4 | 2023 | 1336 | 0.740 |
Why?
|
Blood Platelet Disorders | 1 | 2021 | 61 | 0.740 |
Why?
|
Secretory Vesicles | 2 | 2011 | 128 | 0.670 |
Why?
|
Platelet Aggregation Inhibitors | 5 | 2022 | 3201 | 0.630 |
Why?
|
Blood Coagulation Disorders | 3 | 2021 | 349 | 0.620 |
Why?
|
Lymphatic Vessels | 1 | 2023 | 358 | 0.620 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 749 | 0.620 |
Why?
|
Neoplasms | 7 | 2024 | 22072 | 0.610 |
Why?
|
Platelet Activation | 3 | 2021 | 660 | 0.610 |
Why?
|
Anticoagulants | 7 | 2024 | 4897 | 0.580 |
Why?
|
Cytoplasmic Granules | 1 | 2019 | 573 | 0.560 |
Why?
|
Chemokine CCL5 | 1 | 2015 | 215 | 0.490 |
Why?
|
ADAM Proteins | 1 | 2014 | 240 | 0.410 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2014 | 130 | 0.410 |
Why?
|
Thrombopoiesis | 2 | 2019 | 164 | 0.410 |
Why?
|
Tamoxifen | 1 | 2017 | 963 | 0.400 |
Why?
|
Aspirin | 3 | 2022 | 3364 | 0.400 |
Why?
|
Angiogenesis Modulating Agents | 1 | 2011 | 8 | 0.390 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2014 | 255 | 0.390 |
Why?
|
Lupus Coagulation Inhibitor | 2 | 2024 | 33 | 0.380 |
Why?
|
beta-Alanine | 1 | 2011 | 82 | 0.380 |
Why?
|
Antidotes | 1 | 2011 | 138 | 0.370 |
Why?
|
Mice, Knockout | 3 | 2024 | 14372 | 0.340 |
Why?
|
Thrombosis | 4 | 2020 | 3052 | 0.340 |
Why?
|
Blood Coagulation Factors | 1 | 2011 | 365 | 0.330 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2011 | 177 | 0.330 |
Why?
|
Blood Coagulation | 2 | 2013 | 1157 | 0.320 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3610 | 0.320 |
Why?
|
Venous Thromboembolism | 2 | 2012 | 1864 | 0.310 |
Why?
|
Morpholines | 1 | 2011 | 583 | 0.310 |
Why?
|
Erythrocytes | 1 | 2017 | 2415 | 0.300 |
Why?
|
Catechol O-Methyltransferase | 2 | 2019 | 251 | 0.290 |
Why?
|
Pre-Eclampsia | 2 | 2014 | 1229 | 0.280 |
Why?
|
Thiophenes | 1 | 2011 | 587 | 0.280 |
Why?
|
Angiogenesis Inhibitors | 1 | 2017 | 2049 | 0.280 |
Why?
|
Benzimidazoles | 1 | 2011 | 858 | 0.270 |
Why?
|
Cell Movement | 1 | 2017 | 5206 | 0.240 |
Why?
|
Neoplasm Metastasis | 3 | 2021 | 4902 | 0.230 |
Why?
|
Nitric Oxide | 3 | 2001 | 2141 | 0.220 |
Why?
|
Protein Transport | 1 | 2009 | 1964 | 0.220 |
Why?
|
Platelet Factor 4 | 1 | 2023 | 129 | 0.220 |
Why?
|
Antiphospholipid Syndrome | 2 | 2018 | 165 | 0.220 |
Why?
|
Cathepsin G | 1 | 2022 | 31 | 0.210 |
Why?
|
Prothrombin Time | 2 | 2024 | 116 | 0.210 |
Why?
|
Humans | 46 | 2024 | 760621 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.210 |
Why?
|
Breast Neoplasms | 4 | 2019 | 21025 | 0.210 |
Why?
|
Microtubules | 2 | 2008 | 1072 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.210 |
Why?
|
Partial Thromboplastin Time | 2 | 2024 | 205 | 0.200 |
Why?
|
Signal Transduction | 4 | 2021 | 23376 | 0.200 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2024 | 507 | 0.190 |
Why?
|
Melanoma, Experimental | 1 | 2024 | 562 | 0.190 |
Why?
|
Platelet Aggregation | 3 | 2020 | 805 | 0.180 |
Why?
|
Hemorrhage | 2 | 2023 | 3600 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8624 | 0.180 |
Why?
|
Biological Transport | 2 | 2019 | 2086 | 0.180 |
Why?
|
Primary Health Care | 1 | 2016 | 4647 | 0.170 |
Why?
|
Lung Neoplasms | 1 | 2024 | 13262 | 0.170 |
Why?
|
Epidermal Growth Factor | 1 | 2022 | 695 | 0.170 |
Why?
|
Pulmonary Embolism | 2 | 2024 | 2543 | 0.170 |
Why?
|
Eye Proteins | 4 | 1996 | 633 | 0.160 |
Why?
|
alpha-Tocopherol | 1 | 2019 | 126 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2017 | 3484 | 0.160 |
Why?
|
Lymphopenia | 1 | 2021 | 280 | 0.160 |
Why?
|
Mice | 13 | 2024 | 81208 | 0.160 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2020 | 418 | 0.160 |
Why?
|
Autopsy | 1 | 2022 | 1007 | 0.160 |
Why?
|
Pulmonary Circulation | 1 | 2021 | 743 | 0.150 |
Why?
|
Tumor Burden | 1 | 2024 | 1895 | 0.150 |
Why?
|
Pyridones | 1 | 2023 | 792 | 0.150 |
Why?
|
Cell Membrane | 1 | 2007 | 3682 | 0.150 |
Why?
|
Animals | 15 | 2024 | 167963 | 0.150 |
Why?
|
Heparin | 2 | 2023 | 1652 | 0.140 |
Why?
|
Coculture Techniques | 2 | 2017 | 1342 | 0.140 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 16939 | 0.140 |
Why?
|
Venous Thrombosis | 1 | 2005 | 1299 | 0.130 |
Why?
|
Hematologic Tests | 1 | 2016 | 238 | 0.130 |
Why?
|
Cyclohexanes | 1 | 2015 | 152 | 0.130 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18137 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2471 | 0.120 |
Why?
|
Blindness | 2 | 1996 | 582 | 0.120 |
Why?
|
Cell Adhesion | 1 | 2021 | 3094 | 0.120 |
Why?
|
Interferon-gamma | 1 | 2022 | 3157 | 0.110 |
Why?
|
Receptors, CCR5 | 1 | 2015 | 488 | 0.110 |
Why?
|
Angiogenic Proteins | 1 | 2013 | 101 | 0.110 |
Why?
|
Receptor, PAR-1 | 1 | 2013 | 114 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1933 | 0.100 |
Why?
|
Leukocytes | 1 | 2021 | 2026 | 0.100 |
Why?
|
Pregnancy | 4 | 2024 | 29749 | 0.100 |
Why?
|
Deafness | 2 | 1996 | 457 | 0.100 |
Why?
|
Hematopoiesis | 1 | 2001 | 2050 | 0.100 |
Why?
|
Antioxidants | 1 | 2000 | 1667 | 0.100 |
Why?
|
Interleukin-1beta | 1 | 2018 | 998 | 0.100 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3839 | 0.100 |
Why?
|
S-Nitrosoglutathione | 2 | 2001 | 23 | 0.100 |
Why?
|
Thromboxane A2 | 1 | 2011 | 90 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2023 | 1941 | 0.090 |
Why?
|
Bone Marrow Cells | 3 | 2012 | 2414 | 0.090 |
Why?
|
Endostatins | 1 | 2011 | 168 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2895 | 0.090 |
Why?
|
Female | 16 | 2024 | 391270 | 0.090 |
Why?
|
Factor V | 1 | 2011 | 168 | 0.090 |
Why?
|
DNA Damage | 1 | 2000 | 2442 | 0.090 |
Why?
|
Adenosine Diphosphate | 1 | 2011 | 429 | 0.090 |
Why?
|
Triazoles | 1 | 2015 | 904 | 0.090 |
Why?
|
Gene Expression | 2 | 2022 | 7588 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2448 | 0.090 |
Why?
|
Nerve Tissue Proteins | 4 | 1996 | 4407 | 0.090 |
Why?
|
Abruptio Placentae | 1 | 2011 | 118 | 0.090 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2717 | 0.090 |
Why?
|
Thrombopoietin | 2 | 2001 | 226 | 0.080 |
Why?
|
Abnormalities, Multiple | 1 | 1996 | 1415 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3767 | 0.080 |
Why?
|
Stillbirth | 1 | 2011 | 368 | 0.070 |
Why?
|
Cytokines | 2 | 2019 | 7343 | 0.070 |
Why?
|
Apoptosis | 2 | 2001 | 9501 | 0.070 |
Why?
|
Nitric Oxide Synthase | 2 | 2001 | 908 | 0.070 |
Why?
|
Chromosome Mapping | 1 | 1996 | 4625 | 0.070 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7475 | 0.070 |
Why?
|
Polysaccharides | 1 | 2013 | 1016 | 0.070 |
Why?
|
Cell-Derived Microparticles | 1 | 2008 | 161 | 0.070 |
Why?
|
Intracellular Membranes | 1 | 2007 | 389 | 0.070 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22023 | 0.070 |
Why?
|
Microscopy, Fluorescence | 1 | 2013 | 2651 | 0.070 |
Why?
|
Abortion, Spontaneous | 1 | 2011 | 530 | 0.070 |
Why?
|
X Chromosome | 3 | 1993 | 815 | 0.060 |
Why?
|
Organelles | 1 | 2007 | 267 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2018 | 10446 | 0.060 |
Why?
|
Endothelial Cells | 2 | 2021 | 3539 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11152 | 0.060 |
Why?
|
Lung | 1 | 2022 | 9994 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2021 | 18957 | 0.050 |
Why?
|
Indicators and Reagents | 1 | 2024 | 461 | 0.050 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2001 | 514 | 0.050 |
Why?
|
Blood Coagulation Tests | 1 | 2024 | 270 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3527 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2019 | 11481 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8515 | 0.050 |
Why?
|
Nitric Oxide Donors | 1 | 2001 | 125 | 0.050 |
Why?
|
Embryo, Mammalian | 1 | 2007 | 1674 | 0.050 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2001 | 704 | 0.050 |
Why?
|
False Positive Reactions | 1 | 2024 | 956 | 0.050 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9530 | 0.050 |
Why?
|
Oxypurinol | 1 | 2000 | 8 | 0.050 |
Why?
|
Cyclic GMP | 1 | 2001 | 395 | 0.040 |
Why?
|
Nitroso Compounds | 1 | 2000 | 71 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2021 | 397 | 0.040 |
Why?
|
Catalase | 1 | 2000 | 216 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2018 | 5130 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2007 | 1664 | 0.040 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2001 | 941 | 0.040 |
Why?
|
Indomethacin | 1 | 2000 | 326 | 0.040 |
Why?
|
Carcinoma | 1 | 2011 | 2331 | 0.040 |
Why?
|
Thrombocytopenia | 1 | 2007 | 1174 | 0.040 |
Why?
|
Genes | 2 | 1993 | 1845 | 0.040 |
Why?
|
In Situ Nick-End Labeling | 1 | 2000 | 613 | 0.040 |
Why?
|
Superoxides | 1 | 2000 | 387 | 0.040 |
Why?
|
bcl-2-Associated X Protein | 1 | 2000 | 282 | 0.040 |
Why?
|
Risk Assessment | 2 | 2019 | 24123 | 0.040 |
Why?
|
Internationality | 1 | 2024 | 1004 | 0.040 |
Why?
|
beta 2-Glycoprotein I | 1 | 2018 | 28 | 0.040 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2018 | 62 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 444 | 0.040 |
Why?
|
Caspase 3 | 1 | 2000 | 731 | 0.040 |
Why?
|
beta Carotene | 1 | 2019 | 524 | 0.040 |
Why?
|
Glutathione | 1 | 2000 | 582 | 0.040 |
Why?
|
Superoxide Dismutase | 1 | 2000 | 594 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2023 | 80372 | 0.040 |
Why?
|
Caspases | 1 | 2000 | 878 | 0.040 |
Why?
|
Fibrinogen | 1 | 2020 | 886 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2021 | 1600 | 0.030 |
Why?
|
Cell Line | 2 | 2001 | 15620 | 0.030 |
Why?
|
Hemostasis | 1 | 1999 | 468 | 0.030 |
Why?
|
Disease Progression | 3 | 2021 | 13502 | 0.030 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2018 | 179 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2421 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1246 | 0.030 |
Why?
|
DNA, Complementary | 2 | 1996 | 1991 | 0.030 |
Why?
|
Risk Factors | 2 | 2016 | 74359 | 0.030 |
Why?
|
Models, Biological | 1 | 2011 | 9467 | 0.030 |
Why?
|
Cause of Death | 1 | 2005 | 3725 | 0.030 |
Why?
|
Models, Animal | 1 | 2021 | 2117 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 1996 | 915 | 0.030 |
Why?
|
Prognosis | 3 | 2018 | 29658 | 0.030 |
Why?
|
United States | 1 | 2022 | 72461 | 0.030 |
Why?
|
Retina | 3 | 1993 | 2635 | 0.030 |
Why?
|
Acute Disease | 1 | 2024 | 7269 | 0.030 |
Why?
|
Thromboembolism | 1 | 2020 | 1017 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15757 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1407 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1928 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 1617 | 0.030 |
Why?
|
Introns | 1 | 1996 | 978 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6131 | 0.030 |
Why?
|
Kinetics | 1 | 2000 | 6377 | 0.030 |
Why?
|
Base Sequence | 4 | 1996 | 12446 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1996 | 2753 | 0.020 |
Why?
|
DNA Primers | 1 | 1996 | 2819 | 0.020 |
Why?
|
Male | 10 | 2021 | 359744 | 0.020 |
Why?
|
Vitreous Body | 1 | 1993 | 399 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1996 | 4169 | 0.020 |
Why?
|
Immediate-Early Proteins | 1 | 1993 | 449 | 0.020 |
Why?
|
Molecular Sequence Data | 4 | 1996 | 17624 | 0.020 |
Why?
|
Exons | 1 | 1996 | 2388 | 0.020 |
Why?
|
Fibroblasts | 1 | 2000 | 4090 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2000 | 2919 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 544 | 0.020 |
Why?
|
Platelet Membrane Glycoprotein IIb | 1 | 2008 | 52 | 0.020 |
Why?
|
Child Behavior Disorders | 1 | 1993 | 805 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 1993 | 1387 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6898 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2709 | 0.020 |
Why?
|
Platelet Glycoprotein GPIb-IX Complex | 1 | 2008 | 144 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2000 | 4490 | 0.020 |
Why?
|
Microscopy, Immunoelectron | 1 | 2007 | 317 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3736 | 0.020 |
Why?
|
Contractile Proteins | 1 | 2008 | 240 | 0.020 |
Why?
|
Retinal Diseases | 1 | 1993 | 702 | 0.020 |
Why?
|
Phosphatidylserines | 1 | 2008 | 188 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 6068 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2019 | 3392 | 0.020 |
Why?
|
P-Selectin | 1 | 2008 | 599 | 0.020 |
Why?
|
Mice, Nude | 1 | 2012 | 3607 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 1993 | 1652 | 0.020 |
Why?
|
Cell Communication | 1 | 2012 | 1653 | 0.020 |
Why?
|
Genotype | 1 | 2019 | 12960 | 0.010 |
Why?
|
Peptide Hydrolases | 1 | 2007 | 623 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2012 | 2379 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2019 | 3517 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2008 | 1135 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 1993 | 1647 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10344 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 220352 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9411 | 0.010 |
Why?
|
Actins | 1 | 2008 | 2049 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22053 | 0.010 |
Why?
|
Bleeding Time | 1 | 1999 | 84 | 0.010 |
Why?
|
Thromboxane B2 | 1 | 1999 | 147 | 0.010 |
Why?
|
Selectins | 1 | 1999 | 101 | 0.010 |
Why?
|
Mutation | 2 | 1993 | 29932 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2005 | 65017 | 0.010 |
Why?
|
Aged | 2 | 2021 | 169152 | 0.010 |
Why?
|
Pedigree | 2 | 1993 | 4578 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 54303 | 0.010 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 1993 | 37 | 0.010 |
Why?
|
Sequence Homology | 1 | 1993 | 195 | 0.010 |
Why?
|
Dosage Compensation, Genetic | 1 | 1993 | 207 | 0.010 |
Why?
|
Growth Substances | 1 | 1993 | 768 | 0.010 |
Why?
|
Mucins | 1 | 1993 | 568 | 0.010 |
Why?
|
von Willebrand Factor | 1 | 1993 | 673 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1993 | 2176 | 0.000 |
Why?
|
Organ Specificity | 1 | 1993 | 1955 | 0.000 |
Why?
|
Genetic Linkage | 1 | 1993 | 2381 | 0.000 |
Why?
|
Atrophy | 1 | 1993 | 1627 | 0.000 |
Why?
|
Eye Diseases | 1 | 1993 | 651 | 0.000 |
Why?
|
Hearing Loss, Sensorineural | 1 | 1993 | 781 | 0.000 |
Why?
|
Heterozygote | 1 | 1993 | 2798 | 0.000 |
Why?
|
Syndrome | 1 | 1993 | 3280 | 0.000 |
Why?
|
Brain | 1 | 1993 | 26951 | 0.000 |
Why?
|
Swine | 1 | 1993 | 5899 | 0.000 |
Why?
|
Membrane Proteins | 1 | 1999 | 7850 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1993 | 13451 | 0.000 |
Why?
|
Proteins | 1 | 1993 | 6029 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1993 | 26181 | 0.000 |
Why?
|
Child, Preschool | 1 | 1993 | 42063 | 0.000 |
Why?
|
Child | 1 | 1993 | 79806 | 0.000 |
Why?
|
Adolescent | 1 | 1993 | 87810 | 0.000 |
Why?
|